DR. GUNNAR H ANDERSON M.D.
NPI 1417949819
Internal Medicine - Endocrinology, Diabetes & Metabolism in New Hartford, NY

Q: What is the provider's specialty?

The provider's specialty is Internal Medicine with taxonomy code 207RE0101X and a focus in Endocrinology, Diabetes & Metabolism.

Active since August 22, 2005

1729 BURRSTONE RD, NEW HARTFORD, NY 13413(315) 798-1668(315) 798-1536 Get Directions Write a Review

NPPES record last updated: October 25, 2011. Verified against the NPPES registry weekly; last sync: July 19, 2026.

On this page

About Dr. Gunnar H Anderson M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. GUNNAR H ANDERSON M.D. (NPI 1417949819) is an individual endocrinology, diabetes & metabolism provider in New Hartford, New York, licensed in New York (118177) and active in the NPI registry since August 2005.

NPPES Registry Identity

NPI1417949819

Entity TypeIndividualMale

Primary Taxonomy207RE0101X

Provider Legal NameDR. GUNNAR H ANDERSONCredential: M.D.

Location Address1729 BURRSTONE RDNew Hartford, NY 13413-1001

Mailing Address1729 Burrstone RdNew Hartford, NY 13413-1001 · (315) 798-1668 · Fax (315) 798-1536

Phone(315) 798-1668

Fax(315) 798-1536

Sole ProprietorNo

Enumeration DateAugust 22, 2005

Last NPPES UpdateOctober 25, 2011

✔ NPI 1417949819 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

★ Primary SpecialtyInternal Medicine · Endocrinology, Diabetes & MetabolismAllopathic & Osteopathic Physicians

Taxonomy Code207RE0101X

License✔ Licensed in NY · 118177

Definition

An internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems.

1729 BURRSTONE RD, New Hartford, NY 13413

Open in Google Maps ↗

Other Identifiers 3

Medicaid00462597NY

Medicare UPINC58900

Medicare ID-Type UnspecifiedRA0883

Areas of Expertise CMS Part B claims 9

Services this provider delivered to Medicare fee-for-service patients, from the 2024 & 2026 CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, denosumab, 1 mg J0897

Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.

2,400 services22 patients

Established patient office or other outpatient visit, 20-29 minutes 99213

This is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.

600 services344 patients

Established patient office or other outpatient visit, 30-39 minutes 99214

This is a routine check-up for patients who have previously visited our clinic. It involves a comprehensive review of your health and any ongoing treatments. The consultation lasts between 30-39 minutes, allowing enough time to discuss any concerns.

394 services234 patients

Injection of drug or substance under skin or into muscle 96372

This procedure involves administering medication directly under the skin or into a muscle. A small needle is used to inject the drug, allowing it to be absorbed quickly into the bloodstream. It's a common method for delivering a variety of medications.

81 services25 patients

Telephone medical discussion with physician, 21-30 minutes 99443

This service involves a 21-30 minute phone conversation with a physician. It's a chance for you to discuss your health concerns, symptoms or treatment plans. It's similar to an in-person consultation, but conducted over the phone for your convenience and safety.

61 services47 patients

Influenza vaccine, quadrivalent derived from recombinant dna 90682

The quadrivalent influenza vaccine, made through recombinant DNA technology, is a flu shot that protects against four different flu viruses. This vaccine is produced by genetically modifying a virus, making it safer and more effective. It's a key tool in preventing flu-related illnesses.

41 services41 patients